GET THE APP
+32(800) 709-48
manuscripts@longdom.org
Submit Manuscript
Language
Spanish
Chinese
Russian
German
French
Japanese
Portuguese
Hindi
Telugu
Tamil
Journal of Cancer Research and Immuno-Oncology
ISSN - 2684-1266
Navbar
Journal Home
Editorial Board
Author Guidelines
Aim & Scope
Instruction For Authors
Author Guidelines
Peer Review Process
Publication Ethics & Malpractice Statement
Articles in process
Archive
Submit Manuscript
Journal Contact
+44-77-2385-9429
Ashley Gehrand
Ashley Gehrand
Aurora Research Institute, Aurora Health Care, Milwaukee, WI, USA
Biography
On average, Ashley Gehrand works for one company for 4 years 5 months. Ashley Gehrand has been working as a Adjunct Biology Faculty for Carroll University for 1857 days.
Relevant Topics
Anti-Cancer Drugs
Anti-tumor Antibiotics
Antimetabolites
Antineoplastic Agents
Avastin
Barium Enema
Bladder Carcinoma in Situ
Bone Marrow Stem Cell Transplant
Bone Scan
Breast MRI
Cancer Immunoediting
Cancer Immunology
Cancer Immunotherapies
Cancer Radioimmunotherapy
Cancer Screening
Cancer therapy
Carcinogens
Cellular Immunotherapy
Chemo Resistance
Chemo Side Effects
Chemotherapies
Chemotherapy
Chemotherupatic Agents
Computed Tomography (CT)
Cytotoxic Drugs
Diffusion Tensor Imaging (DTI)
Digital Rectal Exam (DRE)
Electro Chemotherapy
Electrocardiogram (ECG)
Fluorouracil (5-FU)
Functional Magnetic Resonance imaging (fMRI)
Gynecological Cancers
Hormonal Drugs for Cancer Therapy
Immune Suppression
Immunogene response
Immunosurveillance
Immunotherapeutic agents
Immunotherapy or biologic therapy
Magnetic Resonance Imaging (MRI)
Metastasis
Methotrexate
Mitotic Inhibitors
Multi Gated Acquisition (MUGA) Scan
Multiplex Ligation-Dependent Probe Amplification (MLPA)
Necrosis
Nucleic Acid Research
Pap Test
Pharmacology of Cancer Drugs
Pharmocology of Cancer Drugs
Positron Emission Tomography (PET)
Purine Antagoinsts for Cancer Treatment
Radiation Therapy
Radiotherapy
Sigmoidoscopy
Sonography
Squamous Cell Carcinoma
Systems of Immune
Targeted Therapy
Topoisomerase Inhibitors
Transitional cell carcinoma (TCC)
Tumor Immunity
Tumor Marker Tests
Tumorigenesis
Tumour Immunity
Tumour Immunology
Vinblastine
Journal Highlights
Bladder Carcinoma in Situ
Cancer Immunoediting
Cancer Immunology
Cancer Immunotherapies
Cancer Radioimmunotherapy
Cellular Immunotherapy
Chemotherapies
Immune Suppression
Immunogene response
Immunosurveillance
Immunotherapeutic agents
Immunotherapy or biologic therapy
Metastasis
Necrosis
Nucleic Acid Research
Systems of Immune
Transitional cell carcinoma (TCC)
Tumor Immunity
Tumour Immunity
Tumour Immunology
Journal Flyer
Tweets by immunooncol
Top
